Matthew Lunning, DO, FACP

Matthew Lunning, DO, FACPlunning
Associate Vice Chair of Research                                              Associate Professor, Internal Medicine
Division of Oncology & Hematology

Academic Office mailing address:
UNMC Hematology/Oncology Division
986840 Nebraska Medical Center
Omaha, NE 68198-6840

Main Academic Ph. 402-559-8500
New Patient Referral Ph. 402-559-5600
Fax 402-559-6520

Practice Locations:
Fred & Pamela Buffett Cancer Center
505 South 45th Street
Omaha, NE 68105 (map)

Nebraska Medicine Village Pointe
111 N. 175th St.
Omaha, NE, 68118 (map)

Hospital Appointments:
Nebraska Medicine

Education:
Gustavus Adolphus College, St. Peter, MN, BA (2002)
Des Moines University College of Osteopathic Medicine, Des Moines, IA, MD (2006)
University of Nebraska Medical Center, Omaha, NE, Resident (2009)
University of Nebraska Medical Center, Omaha, NE, Chief Resident (2010)
Memorial Sloan-Kettering Cancer Center, New York, NY, Fellow/Chief Fellow (2013)

Interests:
Clinical research in rare hematologic malignancies with a focus on early drug development and experimental correlates that leads to enhanced knowledge of how to treat hematologic malignancies. 

Biographical Sketch:

Matthew Lunning D.O., FACP, is an Associate Professor in the Division of Hematology/Oncology and was recently appointed as an Associate Vice Chair of Research for the Department of Internal Medicine and Medical Director of the Clinical Research Center (CRC). 

He received his medical degree from Des Moines University in 2006.  Dr. Lunning completed his internal medicine residency at UNMC where he served as Chief Medical Resident.  He completed his Hematology/Oncology fellowship and served as the Hematology Chief Fellow at Memorial Sloan-Kettering Cancer Center.  Dr. Lunning returned to UNMC in 2013 and been active in clinic research, research mentoring, education, and patient care. Dr. Lunning was the recipient of the Distinguish Scientist Award in 2019.   

Dr. Lunning has served on several National Comprehensive Cancer Network’s guidelines committees including the Immunotherapy Toxicity & T-cell lymphoma panels. He has served as an invited member of ASCO’s Cancer Education Committee on the Non-Hodgkin Lymphoma.  He is the co-organizer of the Pan Pacific Lymphoma Conference.  

 

Publications at PubMed.Gov:https://https://pubmed.ncbi.nlm.nih.gov/?term=Lunning%2C+M+A&sort=date